Heartburn Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)
Both vonoprazan 10 mg and 20 mg doses met the primary endpoint and showed highly statistically significant greater percentage of 24-hour heartburn free days as compared to placebo (p<0.0001) Data expected to provide the basis for future... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 8, 2023 Category: Pharmaceuticals Source Type: clinical trials

Primary carE PPi dEprescRibing Trial
Conditions:   Heartburn;   Dyspepsia;   Reflux Interventions:   Procedure: de-prescription of PPI via intermittent scheme;   Procedure: de-prescription of PPI via on-demand scheme;   Drug: Alginate Sponsor:   Universitaire Ziekenhuizen KU Leuven Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2022 Category: Research Source Type: clinical trials